Lexaria Bioscience (CSE: LXX) Focus Seemingly on R&D as Licensing Revenues Slow: May. 7, 2019: Lexaria Bioscience (CSE: LXX) Landmark Partnership with Tobacco Titan: Feb. 5, 2019: Lexaria (CSE: LXX) Additional Licensees and Expanded IP: Aug. 31, 2018: Lexaria (OTCQX: LXRP / CSE: LXX) Initial Cannabis Focus; Multi-Market Potential: Jan. 12, 2018
Financials. View the latest financials. Balance SheetIncome StatementCash Flow. Email Alerts. Tear Sheet. Contacts. RSS News Feed. Lexaria Bioscience Corp. (CSE:LXX; OTCQX:LXRP) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.